Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Paul

Showing results (741-750 of 763) with videos related to

Pageof 77
Sort By:
Biorxiv : the Preprint Server for Biology|June 4, 2025
<i>MSH3</i> is a genetic modifier of somatic repeat instability in X-linked dystonia parkinsonismAlan Mejia Maza, Madison Hincher, Kevin Correia, et al.
Brain, Behavior, and Immunity|March 28, 2022
Machine learning based prediction and the influence of complement - Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trialSubash Raj Susai, David Mongan, Colm Healy, et al.
Angewandte Chemie (International Ed. in English)|February 6, 2016
Validating Eaton's Hypothesis: Cubane as a Benzene BioisostereBenjamin A Chalmers, Hui Xing, Sevan Houston, et al.
Acta Neuropathologica Communications|April 9, 2022
Tissue-specific and repeat length-dependent somatic instability of the X-linked dystonia parkinsonism-associated CCCTCT repeatLindsey N Campion, Alan Mejia Maza, Rachita Yadav, et al.
Translational Psychiatry|October 28, 2022
Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosisSubash Raj Susai, Colm Healy, David Mongan, et al.
JAMA Psychiatry|August 29, 2020
Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in AdolescenceDavid Mongan, Melanie Föcking, Colm Healy, et al.
Cell Reports|June 20, 2025
A hexamer tandem repeat RNA embedded within an SVA retrotransposon drives R-loop formation and neurodegenerationLaura D'Ignazio, Alan P R Lorenzetti, Ellen B Penney, et al.
Schizophrenia Bulletin|December 20, 2024
Characterizing the Clinical Trajectory and Predicting Persistence and Deterioration of Attenuated Psychotic Symptoms in Ultra-High-Risk IndividualsCassandra Wannan, Isabelle Scott, Dominic Dwyer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 13, 2021
Promise and challenges of dystonia brain banking: establishing a human tissue repository for studies of X-Linked Dystonia-ParkinsonismCara Fernandez-Cerado, G Paul Legarda, M Salvie Velasco-Andrada, et al.
Early Intervention in Psychiatry|July 1, 2026
Exploring the Relationship Between Inflammatory Biomarkers and Negative Symptoms Subtypes in Individuals at Ultra-High Risk for PsychosisDulari Hakamuwa Lekamlage, Ling Min Amelia Ang, Luba Sominsky, et al.
Pageof 77

Showing results (741-750 of 763) with videos related to

Sort By:
Pageof 77
Biorxiv : the Preprint Server for Biology|June 4, 2025
<i>MSH3</i> is a genetic modifier of somatic repeat instability in X-linked dystonia parkinsonismAlan Mejia Maza, Madison Hincher, Kevin Correia, et al.
Brain, Behavior, and Immunity|March 28, 2022
Machine learning based prediction and the influence of complement - Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trialSubash Raj Susai, David Mongan, Colm Healy, et al.
Angewandte Chemie (International Ed. in English)|February 6, 2016
Validating Eaton's Hypothesis: Cubane as a Benzene BioisostereBenjamin A Chalmers, Hui Xing, Sevan Houston, et al.
Acta Neuropathologica Communications|April 9, 2022
Tissue-specific and repeat length-dependent somatic instability of the X-linked dystonia parkinsonism-associated CCCTCT repeatLindsey N Campion, Alan Mejia Maza, Rachita Yadav, et al.
Translational Psychiatry|October 28, 2022
Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosisSubash Raj Susai, Colm Healy, David Mongan, et al.
JAMA Psychiatry|August 29, 2020
Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in AdolescenceDavid Mongan, Melanie Föcking, Colm Healy, et al.
Cell Reports|June 20, 2025
A hexamer tandem repeat RNA embedded within an SVA retrotransposon drives R-loop formation and neurodegenerationLaura D'Ignazio, Alan P R Lorenzetti, Ellen B Penney, et al.
Schizophrenia Bulletin|December 20, 2024
Characterizing the Clinical Trajectory and Predicting Persistence and Deterioration of Attenuated Psychotic Symptoms in Ultra-High-Risk IndividualsCassandra Wannan, Isabelle Scott, Dominic Dwyer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 13, 2021
Promise and challenges of dystonia brain banking: establishing a human tissue repository for studies of X-Linked Dystonia-ParkinsonismCara Fernandez-Cerado, G Paul Legarda, M Salvie Velasco-Andrada, et al.
Early Intervention in Psychiatry|July 1, 2026
Exploring the Relationship Between Inflammatory Biomarkers and Negative Symptoms Subtypes in Individuals at Ultra-High Risk for PsychosisDulari Hakamuwa Lekamlage, Ling Min Amelia Ang, Luba Sominsky, et al.
Pageof 77